Nilotinib Treatment in Mouse Models of P190 BCR/Abl Lymphoblastic Leukemia

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-6-67
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC